A 66-year-old male with the history of prostate carcinoma, who underwent transurethral resection of the prostate 2 years back with raised PSA level and suspected spinal metastases, was referred for Ga-68-PSMA whole-body simultaneous PET/MRI scan for restaging. A bulky T2W hypointense mass was noted in residual prostate involving right seminal vesicle [ Figure 1a ] with the base of the bladder and mesorectal fascia, showing diffusion restriction [ Figure 1b and 1c], increased K trans [ Figure 1d ] and increased PSMA uptake SUV max = 12.1 to 21.1 [ Figure  1e and 1f]. No enlarged/PSMA avid nodes were seen. Widespread PSMA avid marrow lesions were seen extensively involving the spine [ Figure 1g and 1h] and the remaining skeleton with SUV max = 8.5 to 27.5 [ Figure 1i ]. USG-guided FNAC of thyroid was done which was reported as Hurthle cell neoplasm. Subsequently, total thyroidectomy was performed and the excised gland was sent for HPE which revealed multiple large nodules in both lobes consistent with Hurthle cell adenoma [ Figure 3a ]. In addition, small sub centimeter foci showing tubule-papillary architecture of papillary carcinoma [ Figure 3b ] were also noted in both lobes of thyroid. Subsequently, immunohistochemistry analysis was carried out and the thyroid lesions were found to show intense expression for thyroglobulin [ Figure 3c ] and no expression for PSA [ Figure 3d ] thereby ruling out metastases from PCa and proving that it is a primary thyroid neoplasm. A small pretracheal node sampled during surgery was reported to have metastases from papillary thyroid carcinoma based on its follicular architecture [ Figure 3e and 3f]. The pretracheal node was positive for thyroglobulin and negative for PSA [ Figure 3g and 3h]. Central compartment neck lymph nodes showed no evidence of metastases. There was no lymphovascular, perineural, capsular invasion and extension into the perithyroidal soft tissue associated with any of the tumors. prostate carcinoma. [1] PSMA uptake has been demonstrated in both non-prostatic neoplastic [2] [3] [4] [5] [6] and non-neoplastic lesions. [7, 8] PSMA uptake is also seen in both benign [9] and malignant neoplasms of thyroid. [10] [11] [12] Although rare, metastatic spread to the thyroid gland from primary PCa has been reported in the past. [13, 14] In this patient, metastases to the thyroid was a distinct possibility in view of widespread metastatic disease not observed in this case. So, in a case of PSMA avid thyroid lesion, it is important to differentiate metastases with primary thyroid neoplasm with biopsy before initiating further treatment.
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Discussion
PSMA based simultaneous PET/MRI is a novel imaging technique which has been used in diagnosis of recurrent 
